Craft
Invitae

Invitae

Billable Tests Generated

322 K

Q1, 2022

Revenue

$460.4 M

FY, 2021

Market Capitalization

$708.5 M

2022-09-19

Invitae Summary

Company summary

Overview
Invitae is a company engaged in medical genetic testing. It specializes in genetic diagnostics for hereditary disorders. The company offers genetic tests in various clinical areas including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases, as well as prenatal and perinatal genetic tests.
Type
Public
Founded
2010
HQ
San Francisco, CA, US | view all locations
Website
http://invitae.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Sean Emerson George

    Sean Emerson George, Chief Executive Officer and Co-Founder

    • Michele Cargill

      Michele Cargill, Co-Founder, Key Projects and Advisor to the Chief Executive Officer

    • Alex Furman

      Alex Furman, Co-Founder, Head of Organizational Development

    • Lee Bendekgey

      Lee Bendekgey, Chief Policy Officer

    Operating MetricsView all

    Samples Accessioned

    170K

    Q3, 2020

    Billable Tests Generated

    322K
    24.3%

    Q1, 2022

    Average Revenue per Test

    $372
    2.9%

    Q1, 2022

    LocationsView all

    1 location detected

    • San Francisco, CA HQ

      United States

      1400 16th St, San Francisco

    Invitae Financials

    Summary financials

    Revenue (Q2, 2022)
    $133.2M
    Cash (Q2, 2022)
    $303.6M
    Enterprise value
    $1.9B

    Footer menu